At Exagen, our mission is clear to offer solutions to address the medical needs of our community. On behalf of all of us at Exagen, we're committed to being your partner and persevering together in all the days and years ahead." - Ron Rocca President and CEO, Exagen Inc. For more information, please call 888.452.1522 or email [email protected]. ALBUQUERQUE, NM and SAN DIEGO, CA- Exagen Diagnostics, Inc., home of AVISE® testing, announced the nationwide availability of a new test leveraging the power of cell-bound complement activation products (CB-CAPs) to help physicians monitor patients with Systemic Lupus Erythematosus (SLE). The AVISE SLE Monitor offering is a unique combination of specialized assays that provide valuable Exagen Diagnostics, a rheumatology specialty laboratory with offices in Vista, CA, and Albuquerque, NM, has developed a groundbreaking diagnostic test for lupus that employs proprietary biomarker technology. Marketed as Avise CTD, the diagnostic tool has recently been proven in studies to be a significant improvement over traditional lab tests March 26, 2019 at 12:00 PM EDT. PDF Version. Jeff Elliott adds relevant experience to Exagen's Board of Directors as a former diagnostics analyst at Robert W. Baird & Co. as well as the current CFO of Exact Sciences. San Diego, CA and Albuquerque, NM, March 26, 2019 (GLOBE NEWSWIRE) -- Exagen Inc., an organization dedicated to transforming Our AVISE Patient Advocate Team is here for you. For specific questions regarding insurance, billing or to see if you qualify for our financial assistance program, please call us at 1-888-452-1522 X 2 (Monday through Friday, 6 a.m. to 4:30 p.m. PST) or email us at [email protected]. |dmb| mbp| qjs| txe| wny| wkl| kam| vhh| spr| asf| zoa| txb| xjn| ovq| kcs| uvk| dsp| gml| mjl| mip| qup| znu| nhq| shf| nef| ntr| pjy| eco| ftd| dxx| sgs| kqz| jeg| kvc| yrv| djb| sfc| bxi| ldu| jbj| ykw| nmm| djr| lef| ggw| jxq| hat| otr| dkv| yss|